Search results
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 5 days agoPfizer's Chief Development Officer Roger Dansey said in a statement. CAR-T drugs are developed using...
Why Pfizer Stock Blasted More Than 6% Higher Today
Motley Fool via Yahoo Finance· 4 days agoPfizer (NYSE: PFE) stock got a very effective shot in the arm on Wednesday. This was supplied by its latest earnings... Covid effect not as damaging as...
US opens COVID vaccine to little kids, shots begin next week
AOL· 6 days agoThe U.S. on Saturday opened COVID-19 vaccines to infants, toddlers and preschoolers. The shots will...
The true tragedy of the Covid-19 vaccines
The Telegraph via Yahoo News· 5 days agoVaccination is one of mankind’s most miraculous innovations. The eradication of smallpox, and the retreat of measles and other cruel afflictions, mean...
3 No-Brainer Stocks to Buy in May
Motley Fool via Yahoo Finance· 22 hours ago*Stock Advisor returns as of April 30, 2024 David Jagielski has no position in any of the stocks mentioned. Keith Speights has positions in Pfizer and...
Pfizer Inc (PFE) Q1 2024 Earnings Call Transcript Highlights: Navigating Post-COVID Challenges ...
GuruFocus.com via Yahoo Finance· 4 days agoContinued growth is expected, supported by robust clinical data and effective commercial execution. Q: What is Pfizer's capital allocation strategy, particularly ...
GSK raises forecasts on strong vaccine, HIV drug sales
BioPharma Dive via Yahoo Finance· 5 days agoSales of the shingles vaccine Shingrix and the RSV shot Arexvy helped fuel quarterly revenue totals...
The images that show the two sides of AstraZeneca’s vaccine ‘miracle’
The Telegraph via Yahoo Finance· 6 days agoJamie Scott is nothing if not a fighter. He must be to have survived a reaction to his Covid-19 ...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 4 days agovaccine in partnership with Merck. The shot prompts an immune response against a patient's own tumor...
Safe and Effective? The New York Times Revisits the COVID Jab. - The American Spectator | USA News...
American Spectator· 2 days agoIt has taken three years, but the New York Times has finally admitted that maybe, just maybe, there are some serious side effects to COVID vaccines. AstraZeneca, which has ...